After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to incorporate Proteus's ingestible sensor. The companies have submitted a sensor-embedded version of the antidepressant Abilify for FDA approval.
“Today, patients suffering from severe mental illnesses...
Ingestible sensor company Proteus Digital Health and computer giant Oracle have integrated Proteus's digital health feedback system, which includes an ingestible pill sensor, a wearable patch, and a software system, with Oracle's InForm software for data collection. Clinical trial researchers using Oracle's software will now be able to track patients' medication adherence with Proteus's...
